Canada What amendments to Canada’s restricted drug program mean for patients and practitioners The new rules will facilitate safer access to substances like psilocybin, but many in need won't qualify, experts say Natalia Buendia CalvilloJanuary 11, 2022
Canada Health Canada to increase legal access to psychedelics for therapy Psychedelics firm Numinus says amendments made to the country's Special Access Programme come into effect in January Natalia Buendia CalvilloDecember 28, 2021
Business Numinus ends fiscal year with revenue up 72% to $1.5M, losses of $19M The psychedelics firm has been aggressively expanding lab space while pushing ahead with clinical trials Natalia Buendia CalvilloDecember 10, 2021
Business Field Trip Health opens clinic in Vancouver: Q&A with founder Ronan Levy The new facility will feature the firm's ketamine-assisted therapy program, as well as a range of health and lifestyle services Nick LabaDecember 8, 2021
Medical and Pharmaceutical Common antidepressant escitalopram and psilocybin can be taken together safely: study Research funded by MindMed suggests some antidepressants can reduce the unwanted side effects of psychedelics Natalia Buendia CalvilloDecember 1, 2021
Cannabis Consuming cannabis while on psychedelics makes the experience stronger, researchers say Cannabis and 'classical' psychedelics could act on similar receptors Natalia Buendia CalvilloNovember 4, 2021
Health and Safety Can psilocybin help smokers quit? Johns Hopkins to study impact with NIH grant It’s the first federal grant to be awarded for psychedelic treatment research in 50 years Kathryn TindaleOctober 19, 2021
Cannabis US DEA suggests big increase of cannabis and psilocybin production for research The agency says it supports research into the substances and it's necessary for the FDA to approve new quotas Kathryn TindaleSeptember 1, 2021
Canada Health Canada says patients should access medical psilocybin via clinical trials When asked why patient requests for legal psilocybin are being denied or delayed, the agency said studies are the best route for access Natalia Buendia CalvilloAugust 11, 2021
Canada Advocacy group drafts medical psilocybin framework for regulated access TheraPsil's CEO expects change for psilocybin to come in a matter of months because of the work done for cannabis Kathryn TindaleAugust 4, 2021